series-a
Stage
1
Investors
About
IBI-Ag develops selective biological insecticides for agriculture by leveraging antibody- and protein-based biotechnologies combined with an AI-driven de novo protein design platform to create novel bioinsecticide proteins targeting specific insect pests.
Explore IBI-Ag's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.